oicr-9429 and Prostatic-Neoplasms

oicr-9429 has been researched along with Prostatic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for oicr-9429 and Prostatic-Neoplasms

ArticleYear
WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer.
    Theranostics, 2021, Volume: 11, Issue:10

    Topics: Aged; Animals; Antineoplastic Agents; Apoptosis; Aurora Kinase A; B7-H1 Antigen; Biphenyl Compounds; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclin B1; Dihydropyridines; DNA-Binding Proteins; Drug Resistance, Neoplasm; E2F1 Transcription Factor; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; PC-3 Cells; Polo-Like Kinase 1; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; RNA, Small Interfering; Survivin; Tumor Escape

2021